Author

M. R. Fein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Cunningham-Bussel· 1 shared A. Eberhardt· 1 shared A. H. Jonsson· 1 shared A. Pommier· 1 shared A. R. Bass· 1 shared A. S. Almeida· 1 shared A. Singaraju· 1 shared A. Tirpack· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Cunningham-Bussel

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis

R. Wang, A. Singaraju, K. E. Marks, L. Shakib, G. S. Dunlap, A. Cunningham-Bussel, L. Chen, A. Tirpack, M. R. Fein, D. J. Todd, L. MacFarlane, S. M. Goodman, E. F. DiCarlo, E. M. Massarotti, J. A. Sparks, , D. A. Rao

This study identifies a distinct CD38hi cytotoxic CD8 T cell subset in ICI-induced arthritis, showing clonal expansion and IFN-driven activation.

bioRxiv · Oct 19, 2021 · PreprintImmunology

Cancer cell CCR2 orchestrates suppression of the adaptive immune response

M. R. Fein, X. Y. He, A. S. Almeida, E. Bruzas, A. Pommier, R. Yan, A. Eberhardt, D. T. Fearon, L. Van Aelst, J. E. Wilkinson, C. O. dos Santos, M. Egeblad

This study shows that CCR2 in cancer cells suppresses immune response by reducing CD103+ dendritic cell recruitment and altering immune cell infiltration and activation.

bioRxiv · Dec 27, 2019Cancer Biology